Overview

Physical Health Function and Oxidative Stress After Antioxidant Treatment in GWI: NAC

Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This phase II study will test if N-Acetyl Cysteine (NAC) promotes CNS recovery from chronic oxidative stress and depletion of antioxidants in Gulf War Illness (GWI) participants. Physical function assessments and neuroimaging will be used to determine whether NAC improves the CNS redox state when compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Nova Southeastern University
Collaborators:
Boston University
Miami VA Healthcare System
RTI International
Weill Medical College of Cornell University
Treatments:
Acetylcysteine
N-monoacetylcystine